Pain Management

Jan Keppel Hesselink
  • January 2014, Springer Science + Business Media
  • DOI: 10.1007/978-3-642-13706-8_16

What is it about?

Syringomyelia can induce pain difficult to treat. I reviewed all therapy options in this field and discussed the value of additional, less well known analgesic treatments, such as efficacy and safety of the co-analgesic and supplement palmitoylethanolamide.

Why is it important?

Many patients suffering from pain due to syringomelia are not adequately treated. Therfore thinking out of the box is important.


jan keppel hesselink
Institute Neuropathic Pain

In our practice we have been impressed by the extra analgesic boost we could achieve by adding PeaPure, a pallmitoylethanolamide supplement in 3 times 400 mg/daily, and sometimes we double the dose in case of insufficient response.

Read Publication

The following have contributed to this page: jan keppel hesselink